Pimikralimus in the Treatment of Adopic Dermatitis

dc.contributor.author	Salamova Lola Abdurahimovna
dc.date.accessioned	2026-01-01T10:17:38Z
dc.date.issued	2022-05-30
dc.description.abstract	Data on the mechanisms of formation and methods of effective treatment of atopic dermatitis (AD) are presented. The main directions of pathogenetically substantiated treatment of AD, differentiated correction of concomitant pathology are described in detail. The external therapy of atopic skin lesions in children with the use of modern dermatological cosmetics is presented in particular detail.
dc.format	application/pdf
dc.identifier.uri	https://zienjournals.com/index.php/tjms/article/view/1822
dc.identifier.uri	10.62480/tjms.2022.vol8.pp135-136
dc.identifier.uri	https://asianeducationindex.com/handle/123456789/59362
dc.language.iso	eng
dc.publisher	Zien Journals
dc.relation	https://zienjournals.com/index.php/tjms/article/view/1822/1519
dc.rights	https://creativecommons.org/licenses/by-nc/4.0
dc.source	Texas Journal of Medical Science; Vol. 8 (2022): TJMS; 135-136
dc.source	2770-2936
dc.subject	Atopic dermatitis
dc.subject	treatment
dc.subject	pimecrolimus
dc.title	Pimikralimus in the Treatment of Adopic Dermatitis
dc.type	info:eu-repo/semantics/article
dc.type	info:eu-repo/semantics/publishedVersion
dc.type	Peer-reviewed Article

item.page.files

pagination.showing.labelpagination.showing.detail

item.page.filesection.name: abdurahimovna_2022_pimikralimus_in_the_treatment_of_adopic.pdf
item.page.filesection.size: 200.59 KB
item.page.filesection.format: Adobe Portable Document Format